Search

Your search keyword '"M. Niikura"' showing total 286 results

Search Constraints

Start Over You searched for: Author "M. Niikura" Remove constraint Author: "M. Niikura"
286 results on '"M. Niikura"'

Search Results

101. Inelastic scattering of 72,74Ni off a proton target.

102. First Exploration of Monopole-Driven Shell Evolution above the N=126 Shell Closure: New Millisecond Isomers in ^{213}Tl and ^{215}Tl.

103. Excited-State Half-Lives in ^{130}Cd and the Isospin Dependence of Effective Charges.

104. Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals.

105. Demonstration of nuclear gamma-ray polarimetry based on a multi-layer CdTe Compton camera.

106. Characterization of a nuclear transport factor 2-like domain-containing protein in Plasmodium berghei.

107. A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.

108. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.

109. Dihydroartemisinin Disrupts Zinc Homeostasis in Plasmodium falciparum To Potentiate Its Antimalarial Action via Pyknosis.

110. Synthetic Analogs of the Sponge Sesterterpenoid Alotaketal C are Potent Inhibitors of SARS-CoV-2 Omicron BA.1 and BA.5 Infections of Human Lung Cells.

111. Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484".

112. People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses.

113. SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.

114. Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.

115. Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine.

116. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.

117. Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose.

118. Structure of ^{36}Ca under the Coulomb Magnifying Glass.

119. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination.

120. New antimalarials identified by a cell-based phenotypic approach: Structure-activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety.

121. [Non-participation in social activities of rural older adults: Results from the Toyama dementia survey].

122. Comparison of synbiotics combined with enteral nutrition and prophylactic antibiotics as supportive care in patients with esophageal cancer undergoing neoadjuvant chemotherapy: A multicenter randomized study.

123. Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults.

124. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.

125. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

126. Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose.

127. Identification and Validation of Ikaros ( IKZF1 ) as a Cancer Driver Gene for Marek's Disease Virus-Induced Lymphomas.

128. The association between acute fatty liver disease and nitric oxide during malaria in pregnancy.

129. Development of a rapid and sensitive analytical system for Pseudomonas aeruginosa based on reverse transcription quantitative PCR targeting of rRNA molecules.

130. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy.

131. Boulay et al. Reply.

132. Malaria in the postpartum period causes damage to the mammary gland.

133. Covalent functionalization of polypropylene filters with diazirine-photosensitizer conjugates producing visible light driven virus inactivating materials.

134. Roles and Cellular Localization of GBP2 and NAB2 During the Blood Stage of Malaria Parasites.

136. Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine.

137. IL-4Rα blockade reduces influenza-associated morbidity in a murine model of allergic asthma.

138. Shape Changes in the Mirror Nuclei ^{70}Kr and ^{70}Se.

139. Transcriptome analysis of the brown rot fungus Gloeophyllum trabeum during lignocellulose degradation.

140. Marek's disease virus oncogene Meq expression in infected cells in vaccinated and unvaccinated hosts.

141. COVID-19 and COPD.

142. Sequential Nature of (p,3p) Two-Proton Knockout from Neutron-Rich Nuclei.

143. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.

144. Metastable States of ^{92,94}Se: Identification of an Oblate K Isomer of ^{94}Se and the Ground-State Shape Transition between N=58 and 60.

145. G-strand binding protein 2 is involved in asexual and sexual development of Plasmodium berghei.

146. g Factor of the ^{99}Zr (7/2^{+}) Isomer: Monopole Evolution in the Shape-Coexisting Region.

147. Proton Shell Evolution below ^{132}Sn: First Measurement of Low-Lying β-Emitting Isomers in ^{123,125}Ag.

148. 78 Ni revealed as a doubly magic stronghold against nuclear deformation.

149. Prominence of Pairing in Inclusive (p,2p) and (p,pn) Cross Sections from Neutron-Rich Nuclei.

150. First Spectroscopy of the Near Drip-line Nucleus ^{40}Mg.

Catalog

Books, media, physical & digital resources